Alnylam Pharmaceuticals, Inc. $ALNY Shares Sold by T. Rowe Price Investment Management Inc.
T. Rowe Price Investment Management Inc. lowered its stake in Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY – Free Report) by 19.3% in the 4th quarter, according to its most recent filing with the SEC. The fund owned 1,753,640 shares of the biopharmaceutical company’s stock after selling 420,344 shares during the period. T. Rowe Price Investment Management Inc. […]
19 Jun 05:53 · The Cerbat Gem